| [1] |
Le Bouteiller P, Bensussan A. Up-and-down immunity of pregnancy in humans[J]. F1000Res, 2017, 6: 1216.
|
| [2] |
Sharma S, Godbole G, Modi D. Decidual control of trophoblast invasion[J]. Am J Reprod Immunol, 2016, 75(3): 341-350.
|
| [3] |
Cuffe JSM, Holland O, Salomon C, et al. Review: Placental derived biomarkers of pregnancy disorders[J]. Placenta, 2017, 54: 104-110.
|
| [4] |
Wang XH, Liu W, Fan DX, et al. IL33 restricts invasion and adhesion of trophoblast cell line JEG3 by downregulation of integrin α4β1 and CD62L[J]. Mol Med Rep, 2017, 16(4): 3887-3893.
|
| [5] |
Pereira de Sousa FL, Chaiwangyen W, Morales-Prieto DM, et al. Involvement of STAT1 in proliferation and invasiveness of trophoblastic cells[J]. Reprod Biol, 2017, 17(3): 218-224.
|
| [6] |
Zheng Q, Dai K, Cui X, et al. Leukemia inhibitory factor promote trophoblast invasion via urokinase-type plasminogen activator receptor in preeclampsia[J]. Biomed Pharmacother, 2016, 80: 102-108.
|
| [7] |
Ko HS, Park BJ, Choi SK, et al. STAT3 and ERK signaling pathways are implicated in the invasion activity by oncostatin M through induction of matrix metalloproteinases 2 and 9[J]. Yonsei Med J, 2016, 57(3): 761-768.
|
| [8] |
Secchi MF, Masola V, Zaza G, et al. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer[J]. Biomol Concepts, 2015, 6(5-6): 415-421.
|
| [9] |
Liu XY, Tang QS, Chen HC, et al. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity[J]. Int J Biol Sci, 2013, 9(6): 564-577.
|
| [10] |
Masola V, Zaza G, Secchi MF, et al. Heparanase is a key player in renal fibrosis by regulating TGF-beta expression and activity[J]. Biochim Biophys Acta, 2014, 1843(9): 2122-2128.
|
| [11] |
Lv B, Zhang B, Hu XY, et al. Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma[J]. Oncol Lett, 2016, 11(2): 1327-1334.
|
| [12] |
Wang YY, Zhou R, Zhou B, et al. Overexpression of heparanase is associated with preeclampsia by inhibiting invasion of trophocytes[J]. Int J Clin Exp Med, 2015, 8(10): 18107-18114.
|
| [13] |
Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases[J]. Cytokine, 2015, 74(1): 5-17.
|
| [14] |
Wedekind L, Belkacemi L. Altered cytokine network in gestational diabetes mellitus affects maternal insulin and placental-fetal development[J]. J Diabetes Complicat, 2016, 30(7): 1393-1400.
|
| [15] |
Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia[J]. Med Princ Pract, 2013, 22 Suppl 1: 8-19.
|
| [16] |
Makris A, Xu B, Yu B, et al. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism[J]. Placenta, 2006, 27(4-5): 445-451.
|
| [17] |
Song L, Zhong M. Association between interleukin-10 gene polymorphisms and risk of early-onset preeclampsia[J]. Int J Clin Exp Pathol, 2015, 8(9): 11659-11664.
|
| [18] |
Tan T, Lu B, Zhang J, et al. Notch1 signaling antagonizes transforming growth factor-beta pathway and induces apoptosis in rabbit trophoblast stem cells[J]. Stem Cells Dev, 2014, 23(8): 813-822.
|
| [19] |
Cheng JC, Chang HM, Leung PCK. TGF-β1 inhibits human trophoblast cell invasion by upregulating connective tissue growth factor expression[J]. Endocrinology, 2017, 158(10): 3620-3628.
|
| [20] |
Poon IK, Goodall KJ, Phipps S, et al. Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammation[J]. Eur J Immunol, 2014, 44(4): 1016-1030.
|
| [21] |
Luan Q, Sun J, Li C, et al. Mutual enhancement between heparanase and vascular endothelial growth factor: a novel mechanism for melanoma progression[J]. Cancer Lett, 2011, 308(1): 100-111.
|
| [22] |
Caruana I, Savoldo B, Hoyos V, et al. Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes[J]. Nat Med, 2015, 21(5): 524-529.
|
| [23] |
Pal S, Ganguly KK, Chatterjee A. Extracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3[J]. Cell Commun Adhes, 2013, 20(5): 105-114.
|
| [24] |
Yang YF, Sun YY, Acott TS, et al. Effects of induction and inhibition of matrix cross-linking on remodeling of the aqueous outflow resistance by ocular trabecular meshwork cells[J]. Sci Rep, 2016, 6: 30505.
|
| [25] |
Deng Q, Chen Y, Yin N, et al. N-acetylglucosaminyltransferase V inhibits the invasion of trophoblast cells by attenuating MMP2/9 activity in early human pregnancy[J]. Placenta, 2015, 36(11): 1291-1299.
|
| [26] |
Fu Y, Wei J, Dai X, et al. Increased NDRG1 expression attenuate trophoblast invasion through ERK/MMP-9 pathway in preeclampsia[J]. Placenta, 2017, 51: 76-81.
|
| [27] |
Duval F, Dos Santos E, Moindjie H, et al. Adiponectin limits differentiation and trophoblast invasion in human endometrial cells[J]. J Mol Endocrinol, 2017, 59(3): 285-297.
|
| [28] |
Rahat B, Sharma R, Bagga R, et al. Imbalance between matrix metalloproteinases and their tissue inhibitors in preeclampsia and gestational trophoblastic diseases[J]. Reproduction, 2016, 152(1): 11-22.
|
| [29] |
Binder MJ, McCoombe S, Williams ED, et al. The extracellular matrix in cancer progression: Role of hyalectan proteoglycans and ADAMTS enzymes[J]. Cancer Lett, 2017, 385: 55-64.
|
| [30] |
Theocharis AD, Karamanos NK. Proteoglycans remodeling in cancer: underlying molecular mechanisms[J]. Matrix Biol, 2017, pii: S0945-053X(17)30313-X.
|
| [31] |
Hunter KE, Palermo C, Kester JC, et al. Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors[J]. Oncogene, 2014, 33(14): 1799-1808.
|
| [32] |
Chen XP, Luo JS, Tian Y, et al. Downregulation of heparanase expression results in suppression of invasion, migration, and adhesion abilities of hepatocellular carcinoma cells[J]. Biomed Res Int, 2015, 2015: 241983.
|
| [33] |
Spyrou A, Kundu S, Haseeb L, et al. Inhibition of heparanase in pediatric brain tumor cells attenuates their proliferation, invasive capacity, and in vivo tumor growth[J]. Mol Cancer Ther, 2017, 16(8): 1705-1716.
|